A follicle-stimulating hormone (FSH) that is easy to learn and easy to use.The Follistim® AQ Cartridge(follitropin beta injection), for use with Follistim Pen®, or Follistim® AQ Vial are prescribed for women undergoing assisted reproductive treatments (ART) such as in vitro fertilization (IVF), and for the induction of ovulation to achieve pregnancy. Follistim® AQ Cartridge was the first follicle stimulating hormone (FSH) treatment available in a pre-filled, pre-mixed solution, approved in the U.S., eliminating the need for patients to mix one or more vials of medication.
Safety information: Follistim® AQ Cartridge - Your healthcare professional will decide on the dose of Follistim® AQ Cartridge to be given. This dose may be increased or decreased as your treatment progresses depending on your individual type of treatment. If you have previously used gonadotropins, your dose may be different with Follistim® AQ Cartridge. Again, your healthcare professional will decide the dose based upon your medical history. - Always follow your healthcare professional’s dosing instructions when administering Follistim® AQ Cartridge. Your healthcare professional has individualized the dose to be administered based on your medical history. Do not change your dose unless instructed by your healthcare professional. - Follistim® AQ Cartridge, like all gonadotropins, is a potent substance capable of causing mild to severe side effects including ovarian hyperstimulation syndrome (OHSS), with or without pulmonary or vascular complications. - Follistim® AQ Cartridge should be prescribed only by physicians who are experienced in infertility treatment. Physicians should advise their patients of treatment risks, including OHSS and multiple births. Follistim® AQ Vial - Follistim® AQ Vial, like all gonadotropins, is a potent substance capable of causing mild to severe side effects including OHSS, with or without pulmonary or vascular complications. - Follistim® AQ Vial should be prescribed only by physicians who are experienced in infertility treatment. Physicians should advise their patients of treatment risks, including OHSS and multiple births. - Always follow your doctor’s dosing instructions when administering Follistim® AQ. Your doctor has individualized the dose to be administered based on your medical history. Do not change your dose unless instructed by your doctor. Please see accompanying Physician Prescribing Information. * Gordon K, Prins M, Schuller K and Lewin J. One million and counting. RBM Online 2006; 12(3);313-4. Estimate based on worldwide utilization of Organon's recombinant FSH (follitropin beta). Follitropin beta is also marketed outside the United States under the tradename of Puregon. |
|